BioPhorum Drug Substance
BioPhorum Drug Substance aims to advance manufacturing and testing excellence by collaborating with biopharmaceutical organizations. Drug Substance supports its members to accelerate technology adoption, simplify post-approval change, and increase confidence in maintaining compliance. Membership gives a voice to companies that want to be at the forefront of delivering resilient supply to patients.
We bring together biomanufacturers, major supply partners, and contract development and manufacturing organizations (CDMOs). Together, these experts develop benchmarks and frameworks which will improve operational agility, speed, quality, value, and sustainability for our members. We are proud that BioPhorum Drug Substance is shaping the regulatory and industry landscape through scientific and risk-based guidance.
Join most of the top 20 pharma companies to see faster adoption of technologies in commercial operations. Our members report a reduced risk through developing common approaches to change and increased process efficiency.
BioPhorum Drug Substance members have a unique and credible voice within the industry. This means that our strategies, tools and recommendations carry the gravitas needed to make impactful change.
Being future-ready is crucial for our members to give them advantages in the market.
For the factory of the future to become a reality, it will need to be:
- Proactive – and predict future outcomes based on historical and real-time data
- Agile – and adapt to schedule and product changes with minimal intervention
- Optimized – and operate with minimum manual intervention and high reliability from automated workflows and synchronized assets
The smart factory will need to focus on digital plant and lab maturity with the integration of digital technology in process monitoring and control.
Therefore, Drug Substance members are focusing on:
- Inspiring and accelerating technology adoption
- Shaping the regulatory and industry landscape
- Increasing process efficiency
- Optimizing production capacity
- Assuring safe and compliant products for patients.
Benefits of collaboration
Our members solve complex problems that cannot be done alone. By sharing best practices and experiences, members can improve operational efficiency, bring products to market faster, and create higher-quality medicines for patients.
Drug Substance members have a competitive edge in tackling current and emerging challenges. It allows leaders to better understand industry trends so they can create strategic and operational plans to address these shifts.
From new technology to material changes and mitigating risks, members work together to agree and adopt best practices.
Drug Substance members have opportunities to interact with and influence regulatory agencies as a single industry voice. Through this, we can build a consensus on new regulatory guidelines which may prevent unnecessary expenses or higher requirements.
Participating in the 14 workstreams and two communities of practice will help you develop your teams into subject matter experts by learning from others in the industry.
Contact BioPhorum Drug Substance
To find out more about how BioPhorum BioPhorum Drug Substance can help your business, enter your details below and a member of our team will be in touch.